Piperazine derivatives having SST1 antagonistic activity

Details Piperazine derivatives having SST1 antagonistic activity Piperazine derivatives having SST1 antagonistic activity

2007-09-18

2007-09-18

Bernhardt, Emily (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S253010, C514S253120, C514S254030, C514S254110, C514S255010, C544S236000, C544S360000, C544S364000, C544S368000, C544S375000, C544S380000

Reexamination Certificate

active

10494898

ABSTRACT:
The invention provides compounds of formula (1)wherein X, R1and R2are as defined in the specification, their, preparation and to their use in treating, e.g., depression, anxiety and bipolar disorders.

REFERENCES:
patent: WO93/01159 (1993-01-01), None
Rolland et al. J. Med. Chem. vol. 48, pp. 6563-6574 (2005).

Affiliated with

Also associated with

Rating

Piperazine derivatives having SST1 antagonistic activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Piperazine derivatives having SST1 antagonistic activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperazine derivatives having SST1 antagonistic activity will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3761720